You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN--(BUSINESS WIRE)--The "Pediatric Vaccines Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The pediatric vaccine market is expected to register a CAGR of 7% during the forecast period, 2020-2025. The growth of the pediatric vaccines market is attributed to the rising burden of chronic diseases, along with the importance and awareness of immunization, technological advancements in vaccines, and an increase in the government and non-government funding in R&D. Companies Mentioned Key Market Trends The Conjugate Vaccine Segment is Expected to Grow at a Significant Rate Conjugate vaccines consist of antigens (poly or oligosaccharides) that are chemically attached to the carrier protein. Attaching the saccharides to protein converts polysaccharides to T-dependent antigens, which elicit robust immune responses in infants and adults. These "glycoconjugate" vaccines elicit T-cell help for B-cells that produce IgG antibodies to the conjugated polysaccharide. The CDC recommends the routine administration of the pneumococcal conjugate vaccine (PCV13 or Prevnar13) for all children below two years of age. Furthermore, the rising focus on research, government initiatives on vaccination, and growing awareness, coupled with the companies' efforts in advancing the vaccines, are expected to have a direct correlation with the market growth. In May 2017, Pfizer's 13-valent Pneumococcal Conjugate Vaccine (PCV 13) to prevent pneumonia was selected for the immunization program in certain states of India. In the first phase of vaccination it covered around 5.15 million babies. Pfizer Inc. has supplied the vaccine through UNICEF, under the auspices of Gavi. Moreover, live attenuated vaccines are expected to register significant growth over the forecast period. The major advantage associated with live attenuated vaccine is that only small doses are required and also no boosters needed, owing to the strong immune response triggered by live attenuated vaccines. The North American Region Holds the Largest Market Share and is Projected to Follow the Same Trend over the Forecast Period The North American pediatric vaccine market is expected to register a significant market share. This is primarily due to the well-established healthcare infrastructure, especially in the United States, and immunization programs. The scheduled children immunization programs under the Centers for Disease Control and Prevention (CDC), high funding, wide commercial availability of vaccines, and the awareness in society regarding vaccines contribute to the sustained growth in the United States. Considering the factors responsible for the large size of the US pediatric vaccines market, the country witnesses the highest percentage of children getting vaccinations. This is well described with the data provided by the Centers for Disease Control and Prevention (CDC), which states that there are around 83.4% of children who get vaccinated for diphtheria, tetanus, and pertussis. Moreover, polio, being one of the important vaccines, is given to almost 92% of the children across the country, whereas MMR and hepatitis B vaccines are received by 91.1% and 90.5% of the children, respectively. Other vaccines, like chickenpox, pneumococcal conjugate vaccine (PCV), and Combined 7-vaccine series, are received by around 90% of the children. Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Rising Burden of Chronic Diseases with the Importance and Awareness of Immunization 4.2.2 Technological Advancements in Vaccines 4.2.3 Increase in the Government and Non-government Funding in R&D 4.3 Market Restraints 4.3.1 Cost of Immunization 4.3.2 Low Medical Coverage and Healthcare Services in Low- and Middle-income Countries 4.4 Porter's Five Forces Analysis 5 MARKET SEGMENTATION 5.1 By Vaccine Type 5.1.1 Monovalent 5.1.2 Multivalent 5.2 By Technology 5.2.1 Live Attenuated 5.2.2 Inactivated 5.2.3 Toxoid 5.2.4 Conjugate 5.2.5 Other Technologies 5.3 By Application 5.3.1 Pneumococcal Disease 5.3.2 Influenza 5.3.3 Measles, Mumps, and Rubella (MMR)? 5.3.4 Other Applications 5.4 Geography 5.4.1 North America 5.4.1.1 United States 5.4.1.2 Canada 5.4.1.3 Mexico 5.4.2 Europe 5.4.2.1 Germany 5.4.2.2 United Kingdom 5.4.2.3 France 5.4.2.4 Italy 5.4.2.5 Spain 5.4.2.6 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 Australia 5.4.3.5 South Korea 5.4.3.6 Rest of Asia-Pacific 5.4.4 Middle-East and Africa 5.4.4.1 GCC 5.4.4.2 South Africa 5.4.4.3 Rest of Middle-East and Africa 5.4.5 South America 5.4.5.1 Brazil 5.4.5.2 Argentina 5.4.5.3 Rest of South America 6 COMPETITIVE LANDSCAPE 7 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/qenoey

Answer: Global Pediatric Vaccines Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com